Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation
MK Safo, TP Ko, ER Schreiter, JE Russell - Journal of molecular structure, 2015 - Elsevier
The phenotypical severity of sickle cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb S, Hb α 2 β 2 s) to contain embryonic ζ globin in place of adult α-globin …
hemoglobin S (Hb S, Hb α 2 β 2 s) to contain embryonic ζ globin in place of adult α-globin …
Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation
MK Safo, TP Ko, ER Schreiter… - Journal of molecular …, 2015 - pubmed.ncbi.nlm.nih.gov
The phenotypical severity of sickle-cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation.
MK Safo, TP Ko, ER Schreiter… - Journal of Molecular …, 2015 - europepmc.org
The phenotypical severity of sickle-cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
[HTML][HTML] Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation
MK Safo, TP Ko, ER Schreiter… - Journal of molecular …, 2015 - ncbi.nlm.nih.gov
The phenotypical severity of sickle-cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation
MK Safo, TP Ko, ER Schreiter, JE Russell - Journal of Molecular Structure, 2015 - infona.pl
The phenotypical severity of sickle cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb S, Hb α2β2s) to contain embryonic ζ globin in place of adult α-globin …
hemoglobin S (Hb S, Hb α2β2s) to contain embryonic ζ globin in place of adult α-globin …
Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation
MK Safo, TP Ko, ER Schreiter… - Journal of Molecular …, 2015 - ui.adsabs.harvard.edu
The phenotypical severity of sickle cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb s, Hb α 2 β 2s) to contain embryonic ζ globin in place of adult α-globin …
hemoglobin S (Hb s, Hb α 2 β 2s) to contain embryonic ζ globin in place of adult α-globin …
Structural basis for the antipolymer activity of Hb ζ2βs2 trapped in a tense conformation.
MK Safo, TP Ko, ER Schreiter… - Journal of Molecular …, 2015 - europepmc.org
The phenotypical severity of sickle-cell disease (SCD) can be mitigated by modifying mutant
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …
hemoglobin S (Hb S, Hb α 2 β s 2) to contain embryonic ζ-globin in place of adult α-globin …